X0303 4 2008-10-16 1 0001262175 TERCICA INC TRCA 0001270921 GRETHLEIN ANDREW J 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005 0 1 0 0 SVP, Pharmacetical Operations Common Stock 2008-10-16 4 D 0 8664 9.00 D 0 D Common Stock 2008-10-16 4 D 0 13500 9.00 D 0 D Employee Stock Option (right to buy) 8.60 2008-10-16 4 D 0 87500 0.40 D 2013-05-16 Common stock 87500 0 D Employee Stock Option (right to buy) 7.40 2008-10-16 4 D 0 12500 1.60 D 2013-08-12 Common stock 12500 0 D Employee Stock Option (right to buy) 0.71 2008-10-16 4 D 0 50000 8.29 D 2015-03-17 Common stock 50000 0 D Employee Stock Option (right to buy) 0.43 2008-10-16 4 D 0 50000 8.57 D 2015-08-16 Common stock 50000 0 D Employee Stock Option (right to buy) 1.63 2008-10-16 4 D 0 66666 7.37 D 2016-03-10 Common stock 66666 0 D Employee Stock Option (right to buy) 3.22 2008-10-16 4 D 0 85000 5.78 D 2017-02-14 Common stock 85000 0 D Employee Stock Option (right to buy) 2.87 2008-10-16 4 D 0 55500 6.13 D 2018-03-25 Common stock 55500 0 D Pursuant to the terms of the Agreement and Plan of Merger, dated June 4, 2008, among Tercica, Inc., Beaufour Ipsen Pharma and Tribeca Acquisition Corporation, a wholly owned subsidiary of Beaufour Ipsen Pharma, each issued and outstanding share of common stock was automatically canceled and converted into the right to receive a per share amount equal to $9.00 in cash, without interest. Represents Restricted Stock Units that were canceled pursuant to the terms of the Agreement and Plan of Merger, in exchange for a cash payment equal to $9.00 per restricted stock unit canceled. This stock option, in which 1/4th vested one year after the grant date and 1/48th of the total number of shares vested each month thereafter, was canceled pursuant to the terms of the Agreement and Plan of Merger, in exchange for a cash payment equal to the excess of the $9.00 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option. /s/ Andrew J. Grethlein 2008-10-20